
French ImCheck get´s a USD103m check by Pfizer and a pack of VCs
With around EUR100m in previous financing rounds ImCheck’s financial position looks 'solidified' to take on the leadership in the gamma-delta T cell...

Cannabis players Canify AS and Bavaria Weed merge to form Canify AG
The merger combines Canify AS’s expertise in the production of pharna-grade medical cannabis with the market position of Bavaria Weed GmbH, as...

Evotec signs contracts with Almirall and Sernova
Under the alliance Evotec is set to discover novel targets or therapeutics for skin diseases such as atopic dermatitis or basal cell carcinoma....

GSK acquires Sierra Oncology for 1.9bn
GSK is paying $1.9 bn in cash ($55 per share) for the deal. This is a 39 per cent premium to the Sierra share price on 12 April and a 63 per cent...

Bayer invests into synthetic TCRs for cell therapy
Sometimes it's not bad to have old contacts like Jak Knowles, CEO of Boston-based Affini-T Therapeutics Inc., which left stealth mode at the J.P....

Abliva decides on a SEK200m financing to fund Phase 2/3 study
Swedish Abliva is focussing on mitochondrial medicine, developing therapeutics for primary mitochondrial diseases, orphan indications of high unmet...

Replacing beef with cellular protein halves deforestation
As the negative environmental impacts of ruminant meat consumption become more evident — including those concerning greenhouse gas...